Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus - Effect of sodium-dependent glucose co-transporter 2(SGLT2) inhibitors on muscle strength in patients with type 2 diabetes mellitus

Ise Red Cross Hospital Department of Metabolic Diseases0 个研究点目标入组 30 人开始时间: 2015年7月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Type 1 diabetes 2) Had ketosis or coma within 6 month 3) Secondary diabetes 4) Patients receiving GLP-1 analogue therapy 5) Poor-controlled diabetes (HbA1c>=10.0 % or fasting blood glucose levels>=250mg/dl) 6) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 7) Patients with complication of severe hepatic disorder, e.g., hepatocirrhosis 8) Renal insufficiency: Ccr<45 mL/min/1.73m2 9) Patients who have serious complication of gastrointestinal disorders or who underwent a surgical operation that is known to affect the absorption of a drug by digestive tract 10) Patients who are susceptible to dehydration 11) Patients who is a chronic heavy drinker 12) Patients with history of urinary infection or genital infection disease 13) Malignancies or other diseases with poor prognosis 14) Pregnant 15) Subjects whose doctor in charge do not agree to join the trial

发起方

Ise Red Cross Hospital Department of Metabolic Diseases